Beta Bionics, Inc.
BBNX
$10.65
-$0.31-2.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.58M | 60.90M | 96.75M | ||
| Total Receivables | 12.00M | 7.46M | 4.45M | ||
| Inventory | 13.32M | 11.29M | 1.25M | ||
| Prepaid Expenses | 2.98M | 2.60M | 908.00K | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 1.05M | 305.00K | 275.00K | ||
| Total Current Assets | 132.92M | 82.56M | 103.62M | ||
|
|
|||||
| Total Current Assets | 132.92M | 82.56M | 103.62M | ||
| Net Property, Plant & Equipment | 11.42M | 11.04M | 6.20M | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 5.30M | 3.35M | 221.00K | ||
| Total Assets | 149.65M | 96.94M | 110.04M | ||
|
|
|||||
| Total Accounts Payable | 2.85M | 2.85M | 1.17M | ||
| Total Accrued Expenses | 13.33M | 11.46M | 7.07M | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.53M | 1.45M | 1.22M | ||
| Total Finance Division Other Current Liabilities | 3.44M | 2.12M | 1.14M | ||
| Total Other Current Liabilities | 3.44M | 2.12M | 1.14M | ||
| Total Current Liabilities | 21.15M | 17.88M | 10.61M | ||
|
|
|||||
| Total Current Liabilities | 21.15M | 17.88M | 10.61M | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 5.73M | 5.85M | 3.00M | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 46.76M | 40.34M | 37.83M | ||
| Total Liabilities | 73.63M | 64.07M | 51.43M | ||
|
|
|||||
| Common Stock & APIC | 51.31M | 49.72M | 26.42M | ||
| Retained Earnings | -296.74M | -278.63M | -229.66M | ||
| Treasury Stock & Other | 65.00K | 58.00K | 137.00K | ||
| Total Common Equity | -245.36M | -228.85M | -203.11M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 321.37M | 261.71M | 261.71M | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 321.37M | 261.71M | 261.71M | ||
|
|
|||||
| Total Common Equity | -245.36M | -228.85M | -203.11M | ||
| Total Preferred Equity | 321.37M | 261.71M | 261.71M | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 76.01M | 32.87M | 58.61M | ||
|
|
|||||